Improvement in loan growth (high single-digits), fee income (mid-teens) and total allowance guidance (below S$500m) are key positives for DBS.
Strong 14.5% CET1 and lack of M&A target underpin dividend upside for DBS in FY21F.
Reiterate ADD. Reassuring outlook on asset quality and large management overlay buffers (~S$1.5bn) lay the foundations for reliable business growth.
DBS the Only Bank With Earnings Outperformance in 2Q21
DBS (SGX:D05) was the only bank to outperform our and consensus’ earnings expectations in 2Q21, having recorded a model-led writeback of general provisions (~S$85m or 8bp). Broadly, DBS’s revenue trends were consistent with what was seen across peers, with wealth management and treasury income accounting for most of the total income q-o-q decline.
While DBS had set aside the lowest level of impairments amongst peers at 8bp in 2Q21, its NIM decline was also the steepest, falling 4bp q-o-q to 1.45% as repricing effects and lower yields from its excess deposits come through.
On balance, DBS's 1H21 net profit was above at 57%/58% of our/consensus FY21F estimates. DBS also reinstated quarterly dividend of S$0.33 in 2Q21 – we thus pencil in S$1.17 dividend from DBS for FY21F (from S$1.08 previously).
Positive Asset Quality Outlook Backed by ~S$1.5bn Overlays
DBS management’s view of asset quality cut our credit cost expectations to ~10bp in FY21F (from 16bp) to reflect the improved outlook.
Strong Business Momentum Supported by Solid Cost Control
Business momentum was strong in Lakshmi Vilas Bank accounting for about ~2% pt of the opex growth (+3% y-o-y) in 1H21.
Reiterate ADD on DBS With Higher Target Price
We raise DBS's FY21-23F earnings per share forecast by ~1-4% as we factor in lower impairments, slightly stronger loan growth (~9% in FY21F) and lower NIMs as excess deposits weigh on NII.
While DBS maintains its stance to pay consistently high dividends in line with earnings, its 14.5% CET1 ratio allows for opportunistic M&A, if available. Fed rate hikes are a re-rating catalyst.
Downsie risks are a new wave of COVID-19-related lockdowns.
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....